Engineers Gate Manager LP Sells 11,031 Shares of Chemed Corporation $CHE

Key Points

• Engineers Gate Manager LP cut its Chemed stake by 85.4% in the second quarter, selling 11,031 shares and retaining 1,884 shares worth approximately $877,000. Institutional investors collectively own 95.85% of Chemed.
• Chemed reported stronger-than-expected quarterly results, with EPS of $6.06 versus the $5.60 consensus and revenue of $673.25 million, up 8.8% year over year. The company issued fiscal 2026 EPS guidance of $25.00–$25.75.
• Analysts maintain a generally cautious outlook, with one Buy and five Hold ratings and a consensus price target of $530.75. Chemed also raised its quarterly dividend from $0.60 to $0.70 per share, producing an annualized yield of about 0.6%.

Engineers Gate Manager LP cut its stake in shares of Chemed Corporation (NYSE:CHE - Free Report) by 85.4% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,884 shares of the company's stock after selling 11,031 shares during the quarter. Engineers Gate Manager LP's holdings in Chemed were worth $877,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Eukles Asset Management boosted its stake in shares of Chemed by 0.4% in the 4th quarter. Eukles Asset Management now owns 6,056 shares of the company's stock valued at $2,591,000 after purchasing an additional 25 shares during the last quarter. MassMutual Private Wealth & Trust FSB lifted its stake in shares of Chemed by 65.3% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 81 shares of the company's stock valued at $38,000 after purchasing an additional 32 shares during the period. EverSource Wealth Advisors LLC grew its stake in Chemed by 9.4% during the first quarter. EverSource Wealth Advisors LLC now owns 406 shares of the company's stock worth $153,000 after purchasing an additional 35 shares during the period. Cim LLC increased its holdings in Chemed by 1.6% in the first quarter. Cim LLC now owns 2,325 shares of the company's stock worth $878,000 after purchasing an additional 37 shares in the last quarter. Finally, Blue Trust Inc. increased its holdings in Chemed by 2.7% in the first quarter. Blue Trust Inc. now owns 1,637 shares of the company's stock worth $618,000 after purchasing an additional 43 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.

Insiders Place Their Bets

In related news, Director Patrick P. Grace sold 190 shares of the business's stock in a transaction dated Friday, July 31st. The shares were sold at an average price of $532.00, for a total transaction of $101,080.00. Following the transaction, the director directly owned 3,533 shares in the company, valued at approximately $1,879,556. The trade was a 5.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Spencer S. Lee sold 1,000 shares of the business's stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $541.04, for a total transaction of $541,040.00. Following the transaction, the executive vice president owned 13,912 shares in the company, valued at approximately $7,526,948.48. This trade represents a 6.71% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 5,190 shares of company stock valued at $2,803,460 in the last three months. 3.33% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on CHE shares. Royal Bank Of Canada boosted their target price on shares of Chemed from $436.00 to $548.00 and gave the company a "sector perform" rating in a research report on Thursday, July 30th. Oppenheimer raised their price target on shares of Chemed from $500.00 to $590.00 and gave the stock an "outperform" rating in a report on Friday, July 31st. Weiss Ratings raised shares of Chemed from a "hold (c-)" rating to a "hold (c)" rating in a research note on Friday, July 17th. Bank of America reiterated a "neutral" rating on shares of Chemed in a report on Wednesday, July 29th. Finally, Wall Street Zen cut shares of Chemed from a "strong-buy" rating to a "buy" rating in a research report on Saturday. One research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $530.75.

Chemed Stock Down 0.6%

Shares of NYSE CHE opened at $503.12 on Friday. The stock has a market capitalization of $6.58 billion, a P/E ratio of 25.27, a P/E/G ratio of 2.03 and a beta of 0.51. The company has a 50-day moving average price of $523.01 and a 200-day moving average price of $455.61. Chemed Corporation has a 1 year low of $365.20 and a 1 year high of $557.00. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89.

Chemed (NYSE:CHE - Get Free Report) last posted its earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, topping analysts' consensus estimates of $5.60 by $0.46. The company had revenue of $673.25 million for the quarter, compared to analyst estimates of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The firm's revenue was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, equities research analysts forecast that Chemed Corporation will post 23.55 EPS for the current fiscal year.

Chemed Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th were issued a dividend of $0.70 per share. The ex-dividend date of this dividend was Monday, August 17th. This represents a $2.80 dividend on an annualized basis and a yield of 0.6%. This is a positive change from Chemed's previous quarterly dividend of $0.60. Chemed's payout ratio is presently 14.06%.

Chemed Company Profile

Chemed Corporation is a diversified holding company that operates businesses in the healthcare and residential and commercial services industries. Its primary operations are conducted through VITAS Healthcare and Roto-Rooter.

VITAS Healthcare provides hospice and palliative care for patients with advanced illnesses. Its services are delivered in patients' homes, hospice residences, nursing facilities, hospitals and other care settings, primarily throughout the United States. Care is provided by interdisciplinary teams that may include physicians, nurses, hospice aides, social workers and chaplains.

Roto-Rooter provides plumbing and drain-cleaning services, as well as water cleanup and related services for residential and commercial customers.

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.